Method for producing recombinant oncolytic adenovirus with modified E1a cancer-specific promoter
US11999973B2 · kind B2 · utility
0Cited by
2References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 10, 2018 |
| Grant date | Jun 4, 2024 |
| Priority date | — |
| Expiry date | Jul 30, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10352
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention relates to a method for producing a recombinant virus, e.g., a recombinant oncolytic adenovirus, using an A549 host cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.